|
Oct 1
|
Wave Life Sciences Announces Closing of Upsized Public Offering of Ordinary Shares and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares
|
|
Sep 30
|
Wave Life Sciences to Present at Chardan 8th Annual Genetic Medicines Conference
|
|
Sep 26
|
Biotech Stock Roundup: BHVN, WVE, ZVRA Stocks Up on Updates, BIIB & UCBs Study Data & More
|
|
Sep 26
|
Wave Life Sciences Prices Upsized $200 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
|
|
Sep 25
|
WVE Stock Soars on Upbeat Efficacy Data From Muscle Disease Study
|
|
Sep 25
|
Wave’s stock swells as it eyes approval following Phase II DMD victory
|
|
Jun 25
|
Wave Life Sciences Announces Positive Results from Phase 1b/2a SELECT-HD Trial with First Clinical Demonstration of Allele-Selective Mutant Huntingtin Lowering in Huntington’s Disease
|
|
Jun 25
|
Wave, with new data, plots path forward for Huntington’s drug
|
|
May 12
|
Wave Life Sciences Ltd. (NASDAQ:WVE) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates
|
|
May 10
|
Wave Life Sciences Ltd. (NASDAQ:WVE) Q1 2024 Earnings Call Transcript
|
|
May 10
|
WAVE Life Sciences Reports First Quarter 2024 Financial Results
|
|
May 10
|
Wave Life Sciences First Quarter 2024 Earnings: US$0.24 loss per share (vs US$0.27 loss in 1Q 2023)
|
|
May 9
|
Wave Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update
|
|
May 9
|
Wave Life Sciences Announces Appointment of Dr. Erik Ingelsson as Chief Scientific Officer
|
|
May 7
|
Wave Life Sciences to Present at 2024 RBC Capital Markets Global Healthcare Conference
|
|
May 2
|
Wave Life Sciences First Quarter 2024 Financial Results Scheduled for May 9, 2024
|
|
Apr 30
|
Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency (AATD)
|
|
Apr 23
|
Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA Editing
|
|
Mar 27
|
Wave Life Sciences to Present at Upcoming Investor Conferences
|
|
Mar 15
|
Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks
|